Form 4: VolitionRx GC Nicholas Plummer Reports Changes in Beneficial Ownership

Nicholas Plummer, GC of VolitionRx, reports the vesting of restricted stock units and cancellation of unvested units.

Summary

• Nicholas Plummer, General Counsel of VolitionRx, filed a Form 4 detailing changes in beneficial ownership.
• On August 15, 2024, 17,250 restricted stock units (RSUs) vested due to the achievement of certain corporate performance goals.
• These RSUs are part of an award of 69,000 RSUs granted on September 28, 2023, under the company's 2015 Stock Incentive Plan.
• The vested RSUs are subject to a 3-year time-based vesting schedule, with equal installments vesting on September 28, 2024, 2025, and 2026.
• 22,425 RSUs that did not meet performance goals were cancelled on August 15, 2024.
• Following the reported transaction, Plummer beneficially owns 151,218 shares of common stock.

Sentiment

Score: 6

Explanation: The document is neutral. It reports routine insider transactions. The vesting of some RSUs is positive, while the cancellation of others is slightly negative, balancing out to a neutral sentiment.

Positives

• The vesting of RSUs indicates that certain corporate performance goals were achieved.

Negatives

• The cancellation of 22,425 RSUs suggests that some performance goals were not met.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of RSUs is a common form of executive compensation, aligning management's interests with those of shareholders.

Stakeholder Impact

• The vesting of RSUs aligns management's interests with those of shareholders.
• The cancellation of RSUs may have a minor negative impact on employee morale.

Key Dates